UK +44 (0)1865 849841
Malaysia +60 3 2117 5193

Tag: cannabinoid

The Biosynthesis of Cannabinoids

We recently spoke to Jeremy Friedberg, CSO of  LAVVAN, a company pioneering the biosynthesis of cannabinoids. The conversation was recorded as a podcast, which can be found here.

Read More

The case for biosynthesis: 5 problems with cannabinoids derived from plant cultivation

As we look at the current and future market demands for cannabinoid ingredients, large consumer buyers are focused on purity, consistency and stability of supply. For a host of reasons, cannabinoid suppliers will find it extraordinarily difficult to meet this demand with plant-based production systems.

Read More

5 key requirements for unleashing innovation in the cannabis industry

The cannabis industry faces a systemic problem where the legal nomenclature used to distinguish varietals of ​Cannabis Sativa is known to be unrelated to the genetic identity of the plant.1 Cannabis plants being bought and sold under any specific trade name can be genetically unrelated and may not even have a shared cultivation history.

Read More

11 ways to enable more UK patients to benefit from medicinal cannabis

Medicinal cannabis was legalised in the UK in November 2018, yet there have been fewer than ten new prescriptions made through the NHS. Most of the prescriptions made have been private, and are financially out of reach for most patients, costing up to £2000 per month.

Read More

Why are start-ups such hotbeds for innovation?

This article is republished with kind permission from BioVox. This article was guest authored with Biovox by Willem Broekaert, from V-Bio Ventures.

Read More

Subscribe to Our Newsletter

Get free reports and resources from our world class speakers.
  • This field is for validation purposes and should be left unchanged.

Life Sciences Twitter Feed

Archive